Insmed (LTS:0JAV) Total Assets : $2,053.0 Mil (As of Sep. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Insmed Total Assets?

Insmed's Total Assets for the quarter that ended in Sep. 2024 was $2,053.0 Mil.

During the past 12 months, Insmed's average Total Assets Growth Rate was 8.60% per year. During the past 3 years, the average Total Assets Growth Rate was 27.80% per year. During the past 5 years, the average Total Assets Growth Rate was 36.30% per year. During the past 10 years, the average Total Assets Growth Rate was 29.30% per year.

During the past 13 years, Insmed's highest 3-Year average Total Assets Growth Rate was 207.90%. The lowest was -75.60%. And the median was 13.90%.

Total Assets is connected with ROA %. Insmed's annualized ROA % for the quarter that ended in Sep. 2024 was -45.67%. Total Assets is also linked to Revenue through Asset Turnover. Insmed's Asset Turnover for the quarter that ended in Sep. 2024 was 0.05.

Insmed Total Assets Historical Data

The historical data trend for Insmed's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Insmed Total Assets Chart

Insmed Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Assets

Get a 7-Day Free Trial

742.30

796.16

1,243.51

1,656.44

1,329.84

Insmed Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Total Assets	Get a 7-Day Free Trial															1,324.87	1,329.84	1,159.10	1,810.12	2,052.97

Insmed Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Insmed's Total Assets for the fiscal year that ended in Dec. 2023 is calculated as

Total Assets	=	Total Equity (A: Dec. 2023 )	+	Total Liabilities (A: Dec. 2023 )
	=	-331.923	+	1661.76
	=	1,329.8

Insmed's Total Assets for the quarter that ended in Sep. 2024 is calculated as

Total Assets	=	Total Equity (Q: Sep. 2024 )	+	Total Liabilities (Q: Sep. 2024 )
	=	483.415	+	1569.557
	=	2,053.0

Insmed (LTS:0JAV) Total Assets Explanation

Total Assets is connected with ROA %.

Insmed's annualized ROA % for the quarter that ended in Sep. 2024 is

ROA %	=	Net Income (Q: Sep. 2024 )	/	( (Total Assets (Q: Jun. 2024 )	+	Total Assets (Q: Sep. 2024 ))	/ count )
	=	-882.096	/	( (1810.118	+	2052.972)	/ 2 )
	=	-882.096	/	1931.545
	=	-45.67 %

Note: The Net Income data used here is four times the quarterly (Sep. 2024) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Insmed's Asset Turnover for the quarter that ended in Sep. 2024 is

	Asset Turnover
=	Revenue (Q: Sep. 2024 )	/	( (Total Assets (Q: Jun. 2024 )	+	Total Assets (Q: Sep. 2024 ))	/ count )
=	93.425	/	( (1810.118	+	2052.972)	/ 2 )
=	93.425	/	1931.545
=	0.05

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Insmed Total Assets Related Terms

Thank you for viewing the detailed overview of Insmed's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Insmed Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Insmed Inc (LTS:0JAV) » Definitions » Total Assets

Comparable Companies

Traded in Other Exchanges

INSM:USA IM8N:Germany IM8N:Germany

Address

700 US Highway 202/206, Bridgewater, NJ, USA, 08807

Website

https://www.insmed.com

Insmed Inc is a global biopharmaceutical company transforming the lives of patients with serious and rare diseases. The company's first commercial product is ARIKAYCE (amikacin liposome inhalation suspension), approved in the US for the treatment of Mycobacterium Avium Complex (MAC) lung disease as part of a combination antibacterial drug regimen for adult patients with limited or no alternative treatment options. The company's earlier-stage clinical pipeline includes Brensocatib, a novel oral reversible inhibitor of dipeptidyl peptidase 1 with therapeutic potential in non-cystic fibrosis bronchiectasis and other inflammatory diseases; and INS1009, an inhaled formulation of a treprostinil prodrug that may offer a differentiated product profile for pulmonary arterial hypertension.

Insmed Headlines

No Headlines